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We have isolated the Xenopus ortholog of ADAMTS1 (a disintegrin and metalloprotease with thrombospondin motifs), XADAMTS1, which is
expressed in the presumptive ectoderm, then the Spemann organizer, and later in the trunk organizer region and posterior ectoderm in the Xenopus
embryo. We show that, when overexpressed in the dorsal marginal zone or in the anterior ectoderm by mRNA injection, XADAMTS1 inhibits
gastrulation or generates embryos with an enlarged cement gland, respectively. XADAMTS1 also reduces the expression of Xbra in both whole
embryos and FGF-treated animal caps. These effects of XADAMTS1 are likely to be due to its inhibition of the Ras-MAPK cascade because
XADAMTS1 inhibits the phosphorylation of ERK by FGF4 in animal caps. Deletion analysis of XADAMTS1 revealed that a combination of the
signal peptide and the C-terminal region containing the thrombospondin type 1 repeats is necessary and sufficient for this function, whereas the
metalloprotease domain is dispensable. In addition, loss-of-function analysis with antisense morpholino oligos showed that knockdown of
XADAMTS1 sensitizes animal caps to Xbra induction by FGF2. These data suggest that secreted XADAMTS1 negatively modulates FGF
signaling in the Xenopus embryo.
© 2006 Elsevier Inc. All rights reserved.Keywords: Xenopus laevis; Spemann organizer; ADAMTS1; FGF; MAPK; ERK; XbraIntroduction
In early vertebrate embryogenesis, several signal transduction
pathways initiate various developmental processes and inductive
events, such as mesoderm induction by fibroblast growth factor
(FGF) and nodal/activin signaling; dorsalization by Wnt/β-
catenin signaling; ventralization by bone morphogenetic protein
(BMP) signaling; and posteriorization by FGF, Wnt/β-catenin,
and retinoic acid (RA) signaling (Harland and Gerhart, 1997).
The inhibitory factors or modulators of these signaling
molecules also play important roles in inductive events and the
fine tuning of patterning through negative or positive feedback
loops (Bouwmeester, 2001; Harland and Gerhart, 1997).⁎ Corresponding author. Department of Biological Sciences, Graduate School
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doi:10.1016/j.ydbio.2006.02.041Among the growth factors indicated above, FGFs are known
to play crucial roles in a variety of developmental processes. A
number of studies have shown that FGF signaling is involved in
the formation and maintenance of the mesoderm, neural
induction, and anteroposterior pattern formation (Bottcher and
Niehrs, 2004). In Xenopus laevis, FGF2/bFGF, and FGF4/
eFGF are expressed maternally (Isaacs et al., 1994; Kimelman
et al., 1988), and FGF3, FGF4, and FGF8 are expressed
zygotically in the marginal zone at the gastrula stage (Christen
and Slack, 1997; Isaacs et al., 1995; Lombardo et al., 1998).
Although all FGF signaling is thought to be transduced through
the Ras-MAPK and PI3 kinase pathways after FGF binds to the
FGF receptors (FGFRs) (Bottcher and Niehrs, 2004), there is a
difference in activity between the various FGFs. Whereas FGF2
and FGF4 are potent mesoderm inducers (Isaacs et al., 1994;
Kimelman et al., 1988), FGF8 represses mesoderm formation
and stimulates neuronal differentiation, preferentially through
FGFR4 (Hardcastle et al., 2000). Moreover, FGF signaling is
negatively modulated at various levels possibly due to its
pivotal roles in early developments. Postulated negative
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as Sprouty, Spread, MAPK phosphatase-3 (Mkp3), and FRS2α
(Echevarria et al., 2005; Hacohen et al., 1998; Lax et al., 2002;
Wakioka et al., 2001), and transmembrane proteins such as Sef
(“similar expression to FGF genes”) and Nou-darake/FGFRL1
(FGFR-like 1) (Cebria et al., 2002; Furthauer et al., 2002; Tsang
et al., 2002).
In Xenopus, the Spemann–Mangold organizer functions as a
signaling center for primary axis formation by expressing
specific transcription factors and secreting BMP inhibitors. In
addition, the head organizer secretes Wnt inhibitors, whereas
the trunk organizer secretes posteriorizing factors, Wnt and FGF
(Niehrs, 1999). However, it is still unclear how these signaling
cascades are regulated or modulated to function properly. To
address this issue, identification and functional analyses of
novel regulatory proteins in the organizer are required. One of
the Spemann-organizer-specific transcription factors is the LIM
class homeodomain protein, Xlim-1 (Taira et al., 1992).
Activated forms of Xlim-1 promote the formation of a partial
secondary axis in whole embryos when expressed ventrally and
can initiate the expression of the organizer-specific genes
goosecoid, chordin, and Xotx2 in animal caps (Agulnick et al.,
1996; Mochizuki et al., 2000; Taira et al., 1994, 1997). These
data suggest that Xlim-1 is involved in the functions of the
organizer. Therefore, we used differential screening to identify
further genes that are upregulated by Xlim-1 and found several
genes expressed in the organizer region including Xror2
(Hikasa et al., 2002), cerberus (Yamamoto et al., 2003), and
the Xenopus ortholog of ADAMTS1 (XADAMTS1).
ADAMTS1 is a member of the ADAMTS (“a disintegrin and
metalloprotease with thrombospondin motifs”) family. Unlike
the ADAM (“a disintegrin and metalloprotease”) proteins that
have a transmembrane region, the ADAMTS proteins are
secreted proteins which have one or more thrombospondin type
1 repeats (TSRs), a cysteine-rich region (CR), and a spacer
region (SR; previously, the CR was included in the SR but is
deemed distinct from the SR in this work). Nineteen ADAMTS
genes are currently identified in the human genome (Apte,
2004). ADAMTS1was first identified in mouse colon carcinoma
cells (Shindo et al., 2000), and its transcripts are detectable at
mouse embryonic day 10 (E10) to E18 in tissues including the
kidney, placenta, yolk sac, lung, and at much lower levels in
adult tissues (Thai and Iruela-Arispe, 2002). It has been shown
that ADAMTS1 is upregulated in arthritic adult human tissues
(Abbaszade et al., 1999), and that it cleaves a cartilage
proteoglycan, aggrecan, in vitro (Kuno et al., 2000), implying
an association between ADAMTS1 and inflammatory joint
disease. Human ADAMTS1/METH1 may inhibit angiogenesis
in vivo by binding to vascular endothelial growth factor
(VEGF), a member of the platelet-derived growth factor
(PDGF) family (Luque et al., 2003). The aggrecan-cleavage
activity of ADAMTS1 is dependent on the C-terminal CR and
SR, as well as on the metalloprotease catalytic domain (Kuno et
al., 2000). The TSR is known to interact with sulfated
glycosaminoglycans such as heparin and heparan sulfate
(Lawler, 2000). ADAMTS1-null mice have defects in the
kidneys, adrenal glands, and ovaries (Shindo et al., 2000), butthe role of ADAMTS1 in early embryogenesis has not been
clarified at the molecular level.
In this paper, we demonstrate that the Xenopus ortholog of
ADAMTS1 (XADAMTS1) is expressed in the presumptive
ectoderm at the late blastula stage and in the posterior part of
the organizer at the gastrula stage, and that overexpression of
XADAMTS1 negatively regulates FGF signaling in whole
embryos and animal caps. We also show that the C-terminal
region, including the CR, SR, and TSRs, is required and
sufficient for this activity, whereas the metalloprotease and
disintegrin domains are dispensable. In addition, knockdown of
XADAMTS1 by mis-splicing with antisense morpholino oligos
(MOs) upregulates FGF signaling in FGF-treated animal caps.
Our results suggest that XADAMTS1 is a new type of secreted
FGF negative regulator in vertebrate development.
Materials and methods
Embryo manipulations and animal cap assay
Eggs were artificially fertilized with testis homogenates, dejellied in 2%
L-cysteine–HCl (pH7.8), and reared in 0.1×Steinberg's solution at 14–21°C until
the desired stages according to Nieuwkoop and Faber (1967). Animal caps were
dissected from blastulae (stages 8–9) and cultured in 1× MBS (modified Barth's
solution) containing 0.1% BSA (bovine serum albumin, fraction V, Roche) with
or without human FGF2 (Roche) or activin A (a gift from Ajinomoto Co.).
cDNA cloning and sequencing
cDNA library construction and screening were previously described (Hikasa
et al., 2002). A full-length cDNA clone, pBluescript II SK(−)XADAMTS1 [SK
(−)XADAMTS1] was isolated from a gastrula cDNA library (a gift from Dr. B.
Blumberg). A pseudoallele gene was searched with the XADAMTS1 sequence
against a Xenopus expressed sequence tag (EST) database, XDB2 (http://
xenopus.nibb.ac.jp) and the corresponding cDNA clone (XL180c03) which
contains exon 1 and a part of intron 1 was obtained from Drs. N. Ueno and A.
Kitayama. Amino acid sequences of Xenopus and mouse ADAMTS1 were
aligned using ClustalW (http://www.ddbj.nig.ac.jp/homology/clustalw.shtml).
A phylogenic tree was drawn using the TreeView program (http://taxonomy.
zoology.gla.ac.uk/rod/treeview.html) based on the data calculated using the
ClustalW.
Plasmid constructs and mRNA injection experiments
pCS2+XADAMTS1 was constructed as follows. The coding sequence of
XADAMTS1 was amplified by PCR with SK(−)XADAMTS1. The amplified
fragment was digested with ClaI and XhoI and inserted into the BstBI and XhoI
sites of the expression vector pCS2+. Primers used for PCR were as follows:
forward, 5′-ccttcgaaccgccATGTTCAGGGTCGGGTT-3′; reverse, 5′-ccgctcg-
agCTAACTGCAGTTGGCAA-3′. For making deletion constructs, pCS2+
XADAMTS1 was digested with StuI and XbaI (ΔC1), EcoO65I and XbaI
(ΔC2), EcoRV and XbaI (ΔC3), or with NcoI and BglII (ΔMP), and religated
after blunting both ends with Klenow fragment (Takara). The Gene Editor in
vitro Site-Directed Mutagenesis System (Promega) was used to make ΔSP
which was generated by deleting amino acids (aa) 2 to 32 and a metalloprotease
point mutant of XADAMTS1, named E352A, which was generated by replacing
Glu352 (GAA) with Ala (GCA). For construction of SP series, we first inserted a
PCR-amplified prospective signal peptide region (aa 1 to 31; with a ClaI site at
the 5′ end and BstBI-EcoRI sites at the 3′ end) into the ClaI and EcoRI sites of
pCS2+ to make pCS2+SP. Each PCR-amplified C-terminal fragment with BstBI
sites at both ends (for SP-TCSTT, aa 506–928; SP-CSTT, aa 566–928; SP-STT,
aa 688–928; SP-TT, aa 814–928; SP-CS1, aa 566–823; and SP-S, aa 688–823)
was inserted into the BstBI site of pCS2+SP. SP-TCS and -TC were generated by
deleting SP-TCSTT with EcoRV and XbaI or with EcoO65I and XbaI,
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XbaI. C-terminally Myc-tagged ADAMTS constructs were made by inserting
PCR products of the coding region of the XADAMTS1, ΔC1, SP-TCSTT, or
SP-CS construct into the ClaI site of the pCS2+MT vector. For constructing a C-
terminally Myc-tagged FGF2, the coding sequence of FGF2 was excised from a
pCS2+FGF2-4HA plasmid (S. Matsuda, unpublished) and inserted into the
BamHI and ClaI sites of the pCS2+MT vector. Capped RNA for injection
experiments was synthesized as previously described (Hikasa et al., 2002).
Embryos were coinjected with nuclear β-galactosidase (nβ-gal) mRNA (60 pg/
embryo) for lineage tracing. Counting “enlarged cement gland” was carried out
as follows. Because the average size of cement gland was variable in different
batches of embryos, we analyzed two sets of experiments, in which widths of
cement glands were measured using their photos, and the mean value and
standard deviation (SD) were calculated in each group of individual
experiments. As a result, “enlarged cement glands” were defined as their sizes
bigger than the mean plus one SD of control ones (correspondingly 1.3 to 1.4
times bigger than the mean size of control).
Northern blot and RT-PCR
Total RNAwas isolated from embryos at indicated stages, and Northern blot
analysis was performed as previously described (Hikasa et al., 2002). RT-PCR
reaction was carried out as previously described (Osada andWright, 1999). PCR
products were analyzed on a 2% agarose gel. PCR primer sets and reaction cycles
were as follows: XADAMTS1, forward (F): 5′-CCAGTCCATGGCTGAATTT-
CA-3′ [nucleotide positions (nt) 651–671], reverse (R): 5′-TCACCACCAC-
GAGGCTGATA-3′ (nt 772–753), 26 cycles; Xbra, F: 5′-GAATGGTGGAGGQ
CCAGATTATG-3′ (nt 450–471), R: 5′-ATGCGGTCACTGCTATGAACTG-3′
(nt 586–565), 26 cycles; goosecoid, F: 5′-AGGCACAGGACCATCTTCACCG-
3′, R: 5′-CACTTTTAACCTCTTCGTCCGC-3′ (Gawantka et al., 1995), 26
cycles; and histone H4, F: 5′-CGGGATAACATTCAGGGTATCACT-3′, R: 5′-
ATCCATGGCGGTAACTGTCTTCCT-3′ (Niehrs et al., 1994), 24 cycles. Real-
time RT-PCR analysis was performed using the ABI PRISM 7000 Sequence
Detection System (Applied Biosystems) with PCR primers and TaqMan probes
as follows: Xbra, F: 5′-CGAGAAGGAGCTGAAGGTTAGC-3′, R: 5′-TCG-
TTGGTGAGCTCCTTGAA-3′, TaqMan probe (T): 5′-TGGAGGAGC-
GGGACCTGTGG-3′; goosecoid: F: 5′-TGGCCCCGCAGATTACAG-3′, R:
5′-CATTCACCCCTTGAAGAGTAGATGT-3′, T: 5′-TTTATAACC-
GAGCCGTGGCCC-3′; EF-1α: F: 5′-CCCTGCTGGAAGCTCTTGAC-3′, R:
5′-GAGGCAGACGGAGAGGCTTAT-3′, T: 5′-TTTGCCACCATCTCGCC-
CAACC-3′ (Osada et al., 2003). All real-time PCR assays were performed in
duplicate, and error bars represent deviations of two values.
nβ-Gal staining, whole-mount in situ hybridization, and sectioning
nβ-gal activity was visualized by staining with Red-Gal (Research
Organics). Whole-mount in situ hybridization (Harland, 1991) was performed
with an automatic system (Automated ISH System AIH-101, ALOKA).
Antisense probes were transcribed from linearized plasmid DNA of pBluescript
II SK(−) XADAMTS1, Xbra (Smith et al., 1991), FGF4/eFGF (Isaacs et al.,
1995), FGF8 (Endo et al., 2000), goosecoid (Cho et al., 1991), and chordin
(Sasai et al., 1994) using DIG RNA Labeling Mix and T7 or T3 RNA
polymerase (Roche). BM Purple (Roche) was used for chromogenic reactions.
Embryos were cleared with benzyl benzoate/benzyl alcohol (2:1) (BB/BA).
Hemisections were made as described (Hikasa et al., 2002). Some stained
embryos were embedded in paraffin wax and sectioned at 10–15 μm.
Western blots and whole-mount immunostaining
For detection of diphospho-ERK, 10 animal caps were lysed in 25 μl of lysis
buffer (10 mMTris–HCl, pH 7.5, 100 mMNaCl, 5 mMEDTA, 0.5%Nonidet P-Fig. 1. Alignment of the predicted protein sequences of Xenopus and mouse ADAMTS
or in the mature region, respectively. Lines indicate the signal peptide (blue), meta
repeats (TSR1 through TSR3, yellow), cysteine-rich region (CR, purple), and spacer
Ten conserved cysteine residues in the CR are colored in red. (B) Relationships of am
20, and their X. tropicalis orthologs (XtADAMTS) which are retrieved from the X. tro
red. Human ADAM12 and Xenopus ADAM13 were used as outgroups of the ADA40, 2 mM PMSF, 25 μM Leupeptin, 0.2 U/ml Aprotinin) with 1 mM NaVO3.
The lysate was microcentrifuged at 4°C for 15 min. Supernatants were mixed
with SDS sample buffer, separated by 12.5% SDS-PAGE, and transferred to
Immobilon-P (Millipore). Immunoreaction and detection were performed
following the ECL kit protocol (Amersham Biosciences). Antibodies used in
this study were rabbit anti-phospho-p44/42 MAPK antibody (for dipho-
sphorylated ERK1 and ERK2; Cell Signaling), anti-p44/42 MAP kinase
antibody (for ERK1/2, Cell Signaling), anti-β-tubulin (Sigma), and horseradish
peroxidase-conjugated donkey anti-rabbit IgG, and sheep anti-mouse IgG
antibodies (Amersham Biosciences). Whole-mount immunostaining was done
essentially as described previously (Hiratani et al., 2001), except for alkaline
phosphatase-conjugated anti mouse IgG (Promega) as a secondary antibody and
BM Purple for chromogenic reactions. MZ15 (a gift from Dr. F. Watt) was used
as a primary antibody for notochord staining, and 12/101 was used for muscle
staining.
Heparin-binding assay
Analysis of XADAMTS1 binding to heparin was performed using Affi-
Gel® Heparin Gel (Bio-Rad Laboratories). Nine embryos injected with mRNA
for Myc-tagged constructs were lysed in 90 μl of lysis buffer, and cell lysates
were microcentrifuged. 20 μl of the supernatant was added with 190 μl of the
lysis buffer and incubated with 20 μl of heparin gel suspension for 2 h at 4 °C.
The heparin beads were washed twice with lysis buffer containing 100 mM to
1 M of NaCl, and boiled in SDS sample buffer. Myc-tagged proteins were
analyzed by Western blotting with anti-myc antibody 9E10 (BIOMOL) and
IRDye™800CW conjugated anti-mouse IgG (Rockland). Detection was carried
out using the Odyssey Infrared Imaging system (LI-COR Biosciences).
Antisense morpholino experiments
MOs against exon 1–intron 1 boundary sequences of presumptive
XADAMTS1 pseudoalleles, XADAMTS1a and XADAMTS1b, were obtained
from Gene Tools LLC (MOa for XADAMTS1a, 5′-TAACAGTGACA-
TACCTGTGGGTGGC-3′; MOb for XADAMTS1b, 5′-GGTGTAACA-
TACCTGTGGGTGGCAT-3′). Five mismatched MO (5 mmMO: 5′-
GGTcTAAgATAaCTGTGGcTGcCAT-3′; lower cases are mismatched with
MOb) was used as negative control. Prior to designing MOs, RNA splice
junctions for XADAMTS1a and XADAMTS1b were identified by alignment of
cDNA sequences with the Xenopus tropicalis genome sequence (http://genome.
jgi-psf.org/Xentr3/Xentr3.home.html). XADAMTS1a and XADAMTS1b ge-
nomic DNA fragments were PCR-amplified with X. laevis genomic DNA (a
gift from Dr. T. Shiroishi) and primers specific to exons 1 and 2 (5′-
GAGTATTTGATCCAACC-3′ and 5′-CATGGTCTCCACATAAC-3′ from the
XADAMTS1a gene, respectively) and sequenced. MOs were dissolved in water
and injected into the animal pole region of two-cell stage embryos.
Results
Isolation of Xenopus ADAMTS1 cDNA
We identified the Xenopus ortholog of ADAMTS1 from a
subtracted cDNA library as a gene with expression upregulated
by an active form of Xlim-1, Xlim-1/3m, in animal caps (Hikasa
et al., 2002). A longer cDNA clone of XADAMTS1, SK(−)
XADAMTS1, contains 2784-bp of coding sequence (GenBank
accession no. AB252965). This gene was also referred to as
XADAMTS1a when discriminated from its possible1. XADAMTS1 shares 69.7% or 79.5% identity with mouse ADAMTS1 overall
lloprotease domain (pink), disintegrin domain (green), thrombospondin type-1
region (SR, sky blue). The metalloprotease catalytic site is marked by a red box.
ino acid sequences among XADAMTS1, human ADAMTS proteins 1 through
picalis genome sequence (the Joint Genome Institute). XADAMTS1 is colored in
MTS family for constructing a phylogenic tree.
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a partial cDNA clone (XL180c03) found in an EST database (see
Materials and methods). XADAMTS1 contains a signal peptide,pro-domain, metalloprotease domain, and disintegrin domain,
followed by one TSR, CR, SR, and two additional TSRs (Fig.
1A). The deduced amino acid sequence of XADAMTS1without
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ADAMTS1, with 79.5% identity (Fig. 1A). The metalloprotease
region contains a conserved zinc-binding catalytic center
(indicated by a red box in Fig. 1A). Ten cysteine residues in
the CR are conserved among the members of the ADAMTS
family and the extracellular matrix protein, papilin (Kramerova
et al., 2000; Tang, 2001). We also found 19 prospective
orthologs of ADAMTS genes including the X. tropicalis
ADAMTS1 (XtADAMTS1) identified in a X. tropicalis genome
sequence database (ver.3, Joint Genome Institute) (Fig. 1B),
suggesting that all the ADAMTS family genes are conserved
among vertebrates.
Expression profile of XADAMTS1 during early embryogenesis
Northern hybridization showed that there is no maternal
expression of XADAMTS1, whereas zygotic expression of 4.8-
kb XADAMTS1 mRNA was apparent as early as the mid-
blastula stage (Fig. 2A). Using whole-mount in situ hybrid-
ization, the expression of XADAMTS1 was first detected at the
late blastula stage in the sensorial layer (stained in purple) but
not or much less in the epithelial layer (the pigmented surface
is seen in brownish color) of the presumptive ectoderm (Fig.
2Ba, inset). The expression of FGF8, which was detected in
both layers of the presumptive ectoderm (Fig. 2Bb), over-
lapped that of XADAMTS1 at least in the sensorial layer. As
shown in Fig. 2Bc, the expression of XADAMTS1 (left panel)
overlaps that of Xlim-1 (right panel) in the dorsal mesoderm,
as well as in the ventral mesoderm (data not shown) at the
early gastrula stage. Together with the result that XADAMTS1
was induced by Xlim-1/3m in animal caps, it is possible that
XADAMTS1 acts downstream from Xlim-1 in the mesoderm.
XADAMTS1 transcripts accumulate in the dorsal mesoderm
and ectoderm during gastrulation, with relatively weak
expression in the ventroposterior region (Figs. 2Bd, e). During
the gastrula and neurula stages, the expression of XADAMTS1
in the posterior mesoderm overlaps that of both FGF4 and
FGF8 (Figs. 2Bf, g) (Christen and Slack, 1997; Isaacs et al.,
1995). At the neurula stages and later, the expression of
XADAMTS1 was detected in a punctate pattern in the posterior
part of the embryo but was excluded from the neural plate
(Fig. 2Bh).
At the early tailbud stage (stage 26; Fig. 2Ca), XADAMTS1
expression was observed in the brain (Figs. 2Cb, e), branchial
arches (Fig. 2Cc), and prospective dermatome (Fig. 2Cd),
whereas expression in the notochord was detected at the late
tailbud stage (stage 31; Figs. 2Cf, g). XADAMTS1 was also
expressed in the heart anlage and pronephros (Figs. 2Cf, g),
suggesting an evolutionarily conserved role for ADAMTS1 in
the formation of these organs (Thai and Iruela-Arispe, 2002).
Because XADAMTS1 is expressed in the marginal zone at the
early gastrula stage, we examined whether XADAMTS1 is
induced by mesoderm-inducing factors. An animal cap assay
showed that XADAMTS1 is induced by activin but not by FGF2
(Fig. 3). Because Xlim-1 is also induced by activin in animal
caps (Taira et al., 1992), this result together with the expression
pattern in the early gastrula (Fig. 2Bc) implies that nodal/activinsignaling induces XADAMTS1 through Xlim-1 in the dorsal
marginal zone at the gastrula stage.
XADAMTS1 overexpression leads to enlargement of the cement
gland and gastrulation defects
To explore the role of XADAMTS1 in early Xenopus
development, we used mRNA injection experiments to over-
express XADAMTS1 or its deletion constructs (Fig. 4A) in the
marginal zone or dorsal ectodermal region. Whereas Xlim-1/3m
initiates secondary axis formation in the ventral marginal zone
(Taira et al., 1994), XADAMTS1 induced neither an apparent
secondary axis (Fig. 4Bb) nor an ectopic muscle tissue in the
injected region as assayed by immunostaining with 12/101 (data
not shown). These data indicate that XADAMTS1 does not
have dorsalizing activity.
We next tested whether early morphogenesis was affected by
injection of XADAMTS1 mRNA into the prospective anterior
ectoderm or dorsal mesoderm. Microinjection of XADAMTS1
mRNA into the dorsal anterior ectoderm elicited embryos with a
wider cement gland (Fig. 4Bf) compared with that of control
embryos (Fig. 4Be). The difference of sizes of cement glands
between XADAMTS1-expressing and control embryos was
confirmed by Student t test at a 5% significance level using two
sets of experiments (XADAMTS1-expressing embryos, n = 22
and 18; control embryos, n = 17 and 18, respectively).
Overexpression of XADAMTS1 in the dorsal marginal zone
inhibited gastrulation, leading to dorsally kinked embryos at the
tailbud stage (Fig. 4Bd). In the embryos injected with 1 to 2 ng
of XADAMTS1, 34 out of 49 mRNA had a greatly reduced
notochord in one side of the open blastopore (Fig. 4Bh, arrow),
whereas the remaining had a notochord split along both sides of
the open blastopore (Figs. 4Bg, h′, arrow). Although the
complete absence of notochord was not observed in
XADAMTS1-expressing embryos, these phenotypes are rem-
iniscent of those of embryos overexpressing a dominant-
negative type of FGFR1 (XFD) (Amaya et al., 1991).
The C-terminal region is sufficient for the function of
XADAMTS1
To identify the functional domains of XADAMTS1 that are
responsible for its effects described above, we used deletion
constructs (Fig. 4A). ΔC1, ΔC2, and ΔSP, which lack the
regions C-terminal to the metalloprotease domain or the signal
peptide respectively, had almost no effect on the size of the
cement gland or on gastrulation (Figs. 4C and D). Unexpect-
edly, ΔMP, which lacks the metalloprotease domain, had
essentially the same effects as wild-type XADAMTS1 (Figs.
4C and D). A point-mutated construct, E352A, in which the
glutamic acid residue critical for the catalytic activity of
XADAMTS1 was changed to alanine, also affected gastrula-
tion movement (data not shown). These results indicate that
the signal peptide and the C-terminal region but not the
metalloprotease domain are required for the XADAMTS1
activity observed in the embryo. To further analyze the
function of the C-terminal region, we overexpressed constructs
Fig. 2. Analysis of XADAMTS1 expression. (A) Northern blot analysis. Total RNA (10 μg) from different developmental stages was loaded in each lane. Bands of 18S
rRNA stained with ethidium bromide were used for a loading control. (B) Whole-mount in situ hybridization for XADAMTS1 mRNA during blastula to neurula
stages. (a, b) Late blastulae (stage 8.5) bisected vertically after staining for XADAMTS1 (a) and FGF8 (b). Magnified images of the enclosed regions are shown in the
inset. (c) Comparison of expression domains between XADAMTS1 and Xlim-1 at the gastrula stage (stage 10.5). Embryos were bisected into left and right halves and
subjected to whole-mount in situ hybridization for XADAMTS1 (left panel) and Xlim-1 (right panel), respectively. Dorsal is to the right (XADAMTS1) or the left (Xlim-
1). (d) Vegetal view of a mid-gastrula embryo (stage 11.5) cleared with BB/BA. (e–g) Late gastrulae (stage 12) bisected sagittally after staining for XADAMTS1 (e),
FGF4 (f), and FGF8 (g). Dorsal is upwards; anterior is to the left. (h) Dorsal view of neurula (stage 18). Anterior is upwards. (C) Expression patterns of XADAMTS1
at tailbud stages. (a) Early tailbud stage embryo (stage 26). Transverse (b–d) and horizontal (e) sections of stained tailbud stage embryos (stage 26). (f) Late tailbud
stage embryo (stage 31) cleared with BB/BA. (g) Transverse section of a stained late tailbud stage embryo (stage 31). Dorsal is upwards (a–d, f, g). Anterior is to the
left (a, e, f). ba, branchial arch; d, dermatome; e, eye; h, heart anlage; n, notochord; nt, neural tube; ov, otic vesicle; pn, pronephros. Arrowheads indicate the dorsal
blastopore.
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from the protease domain. As shown in Fig. 4D, SP-TCSTT,
SP-CSTT, and SP-TCS, which contain the CR and SR with
TSR1 or TSR2/3, evoked effects similar to that of wild-type
XADAMTS1. However, constructs which have no or only
partial TSR (SP-CS1 or SP-CS2) or which lacks the SR
domain (SP-TC) did not. These data suggest that the C-terminal region containing the CR and SR with TSR1 (SP-
TCS) or TSR2/3 (SP-CSTT) is sufficient for the inhibition of
gastrulation. In addition, the TSR domain on either side of the
CR/SR domain or the SR domain is necessary for the activity
of the C-terminal region of XADAMTS1, whereas the CR is
not essential but might be needed for the full activity as judged
by comparing SP-CSTT with SP-STT.
Fig. 3. Induction of XADAMTS1 by activin. Animal caps were treated with
FGF2 (100 ng/ml) or activin (190 pM) and collected at the gastrula stage (stage
10.5) for RT-PCR. Xbra and goosecoid were used as positive controls for FGF
and activin, respectively; histone H4 was used as a loading control.
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To test whether the inhibition of gastrulation resulted from a
failure of mesoderm formation in XADAMTS1-overexpressing
embryos, we examined the expression of mesoderm markers
Xbra, goosecoid (gsc), and chordin, by whole-mount in situ
hybridization. As shown in Fig. 5A, the expression of the
posterior mesoderm marker, Xbra, was dramatically reduced in
the XADAMTS1 mRNA-injected area as visualized by staining
of coexpressed nβ-gal, whereas the expression of dorsal
mesoderm markers, gsc and chordin were not reduced. This
effect is similar to that of XFD, which inhibits Xbra expression
but not gsc as reported (Amaya et al., 1991). As shown in Fig.
5B, the expression of Xbra was strongly or partially reduced in
more than 90% of the embryos injected with XADAMTS1
mRNA. Furthermore, the constructs with gastrulation inhibi-
tion activity (SP-TCSTT, SP-CSTT, and SP-TCS) also
repressed the expression of Xbra. These results suggest that
XADAMTS1 can inhibit proper mesoderm formation by
repressing the expression of Xbra, and that the C-terminal
region downstream from the disintegrin domain is sufficient for
this activity. The construct lacking the CR (SP-STT) had
weaker inhibitory activity on the expression of Xbra than the
SP-CSTT construct, indicating that the CR in the C-terminal
region is required for its effective inhibition of mesoderm
formation.
Because Xbra is a direct target of FGF and activin signaling
(Smith et al., 1991), we conducted animal cap assays to assess
whether XADAMTS1 inhibits these signaling pathways. We
first observed that XADAMTS1 inhibited the expression of
Xbra induced by FGF2 in animal caps as assayed by in situ
hybridization (data not shown). To examine the activity of
XADAMTS1 more quantitatively, expression levels of Xbra
were analyzed by real-time PCR. As shown in Fig. 6A, Xbra
was induced by treatment with FGF2 in animal caps, and thisinduction was inhibited by expression of XADAMTS1 in a dose-
dependent manner, similar to XFD. In contrast, expression of
goosecoid induced by activin in animal caps was not
substantially affected by expression of XADAMTS1 or XFD
(Fig. 6B, upper panel), whereas activin-induced Xbra expres-
sion was dose-dependently reduced by coexpression of
XADAMTS1 or XFD (Fig. 6B, lower panel). Because it has
been reported that activin-mediated induction of Xbra, but not
gsc, depends on FGF signaling (Cornell and Kimelman, 1994),
these results suggest that XADAMTS1 preferentially inhibits
FGF signal transduction.
Because FGF activates the expression of Xbra via the
Ras-MAPK signaling pathway (Gotoh et al., 1995), we next
examined whether XADAMTS1 inhibits the Ras-MAPK
signaling activated by FGF as assayed by the dipho-
sphorylation of ERK1/2, members of the MAPK family
(Umbhauer et al., 1995). As shown in Fig. 6C, XADAMTS1
inhibited the phosphorylation of ERK1/2 by FGF4, but not
by a constitutively active form of Ha-Ras (Ha-Ras*), similar
to a dominant-negative FGFR4a (ΔFGFR4a). These data
indicate that XADAMTS1 inhibits the Ras-MAPK signaling
activated by FGF not downstream from Ras and also
eliminate the possibility that XADAMTS1 inhibits FGF
signaling due to its nonspecific cytotoxic effects. We further
assessed the latter point using whole embryos and showed
that the inhibition of Xbra expression by XADAMTS1 in the
dorsal marginal zone was rescued by coinjected Ha-Ras*
mRNA (Fig. 6D).
XADAMTS1 interacts with heparin
Mature mouse and human ADAMTS1 proteins are
bound to the extracellular matrix (ECM) probably through
binding to heparan sulfate (Kuno and Matsushima, 1998;
Rodriguez-Manzaneque et al., 2000). Because heparan
sulfate is a necessary component for FGF ligand-receptor
complex formation (Pellegrini, 2001), we examined whether
the XADAMTS1 protein and its deletion constructs interact
with heparin. In vitro heparin-binding assays were carried
out with heparin beads with different concentrations of
NaCl for washing conditions in comparison with FGF2 that
is known to strongly bind to heparin (Szebenyi and Fallon,
1999). As shown in Fig. 7, wild-type XADAMTS1 and the
C-terminal construct SP-TCSTT but not the C-terminally
deleted construct ΔC1 associated with heparin at 0.1 M
NaCl. At 0.5 M NaCl, the binding of the wild type and
SP-TCSTT was greatly reduced compared to FGF2 but was
still retained more than that of ΔC1. These data suggest
that XADAMTS1 specifically binds to heparin through the
C-terminal region. In the C-terminal region, the CR/SR was
reported as one of the ECM-binding domains of mouse
ADAMTS1 (Kuno and Matsushima, 1998), and consistently,
the SP-CS1, which contains the CR/SR, bound to heparin
(Fig. 7). Because the SP-CS1 did not inhibit gastrulation or
Xbra expression (Figs. 4D and 5B), it seems that the
heparin-binding activity per se is not sufficient for the
inhibition of FGF signaling by XADAMTS1.
Fig. 4. Effects of overexpression of XADAMTS1 on embryonic development. (A) Schematic representation of XADAMTS1 constructs used in this study. Each domain
is indicated in different color, as follows: blue, signal peptide (SP); white, pro-domain (P); pink, metalloprotease domain (MP); green, disintegrin domain (D); yellow,
thrombospondin type I repeats (TSR1 through TSR3); purple, cysteine-rich region (CR); sky blue, spacer region (SR). The name of each construct is indicated on the
left side. WT, wild-type XADAMTS1. (B) Phenotypes of injected embryos at the tailbud stage (a–f; stage 26; g–h′, stage 29/30). Embryos were injected with β-globin
(negative control; a, e, g) or XADAMTS1 (b–d, f, h, h′) mRNA (1 or 2 ng/embryo) into two blastomeres in the ventral equatorial region (VER; a, b), in the dorsal animal
pole region (AP; c, e, f), or in the dorsal equatorial region (DER; d, g–h′) at the four-cell stage. (g–h′) Embryos stained with the antibody MZ15 were cleared with BB/
BA. Black arrowhead, cement gland; white arrowhead, otic vesicle; arrow, notochord. (C) Percentage of phenotypes when injected into the AP. Amount of mRNA,
1 ng/embryo. Molar ratios of mRNA: WT, 1; ΔC1, 2; ΔC2, 1.4; ΔC3, 1.1; ΔMP, 1.3. In bar graphs: red, dorsally kinked embryo; orange, enlarged cement gland;
yellow, normal; sky blue, others. “Enlarged cement gland” were counted as described in Materials and methods. (D) Percentage of phenotypes when injected into the
DER. Equal molar amounts of mRNA were injected based on the amount of WT mRNA at 1 ng/embryo, except for ΔC1 and ΔC3 (1 ng/embryo). N, number of
injected embryos; exp, number of experiments.
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Fig. 5. Effects of XADAMTS1 on the expression of Xbra. (A) Expression of
mesoderm markers in the embryos injected with XADAMTS1 or XFD. Embryos
were injected with indicated mRNAs together with nβ-gal mRNA as a lineage
tracer into the DER at the four-cell stage, and the expressions of Xbra,
goosecoid, and chordin were stained in purple by whole-mount in situ
hybridization. nβ-gal was stained in red. Subtle expansion of goosecoid and
chordin expression in XADAMTS1-expressing embryos were probably due to
gastrulation arrest by XADAMTS1. (B) The C-terminal region is sufficient for
the inhibition of Xbra expression. Xbra expression was strongly (a) or partially
(b) reduced by XADAMTS1, compared to the control (c). (d) Percentage of
phenotypes. Embryos were injected with XADAMTS1 mRNA (1 ng/embryo) or
the equal molar ratio of mRNAs for other constructs as indicated. In bar graph:
red, strongly reduced; orange, partially reduced; yellow, normal; N, number of
embryos; exp, number of experiments.
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response to FGF2 in animal caps
To further elucidate the role of endogenous XADAMTS1,
we carried out knockdown experiments using antisense MOs
against the boundary between exon 1 and intron 1 (Fig. 8A).
Because XADAMTS1 is likely to have two pseudoalleles, XAD-
AMTS1a and XADAMTS1b, we PCR-amplified the intron 1 with
X. laevis genomic DNA and primers corresponding to exons 1
and 2 of XADAMTS1a, and obtained two distinct intron 1
sequences corresponding to the XADAMTS1a and XADAMTS1bgenes. Based on these sequences, we designed antisense MOs,
MOa and MOb, targeting the exon–intron boundary for
XADAMTS1a and XADAMTS1b pre-mRNAs, respectively. To
knockdown both genes, we used a mixture of MOa and MOb,
designated as MOab, for all experiments. We first confirmed the
effectiveness of MOab as assayed by RT-PCR to detect
unspliced RNAs containing the targeted exon 1–intron 1 splice
junction. As shown in Fig. 8B, a 0.3-kb PCR band from the
spliced transcripts was decreased, and, in turn, a 1.8-kb band
from unspliced transcripts was increased in MOab-injected
embryos. In contrast, these changes were not detected in
5 mmMO-injected embryos, suggesting that MOab can
sequence-specifically inhibit XADAMTS1 by blocking proper
splicing of XADAMTS1 pre-mRNA.
Injection of MOab but not 5 mmMO into the dorsal
equatorial region (DER) elicited embryos with a small head,
but at the gastrula stage MOab-injected embryos were
indistinguishable from 5 mmMO-injected ones both in
morphological appearances and in gene expression as assayed
by Xbra (data not shown). Because the expression of
XADAMTS1 changes from the ectoderm to the mesoderm
during the blastula to gastrula stages, it might not be easy to
identify the primary effect of MOab on gene expression at early
stages in the whole embryo. Therefore, we performed animal
cap assays to knockdown the XADAMTS1 expressed in the
ectoderm at the late blastula stage (Fig. 2Ba) and examined
whether the FGF signaling was enhanced. Animal caps from
MOab or 5 mmMO-injected embryos were incubated with
FGF2 and were subjected to real-time RT-PCR for Xbra. The
expression of Xbra in FGF2-treated animal caps was enhanced
by MOab in a dose-dependent manner, whereas this enhance-
ment was reversed by coinjection of XADAMTS1 mRNA (Fig.
8D). These data suggest that specific knockdown of
XADAMTS1 increases sensitivity to FGF, and that the role of
XADAMTS1 in the ectoderm is to attenuate FGF activity and
perhaps in the mesoderm as well.
Discussion
The results of this study suggest that XADAMTS1 functions
as a negative modulator of FGF signaling. Unexpectedly, the
inhibitory action of XADAMTS1 on FGF signaling occurs
independently of its metalloprotease activity but instead
involves the C-terminal region, including the CR, SR and
TSRs. Moreover, XADAMTS1 is distinct from known FGF
negative-feedback regulators because it is not induced by FGF
and probably functions outside the cell as discussed below.
XADAMTS1 inhibits FGF signal transduction
Some of the 19 ADAMTS proteins have been shown to have
specific substrates for their metalloprotease activities, including
procollagens for ADAMTS2, 3, and 14, the cartilage proteo-
glycan aggrecan for ADAMTS 4 and 5, von Willebrand factor
for ADAMTS13 (Apte, 2004), and aggrecan and versican for
ADAMTS1 (Kuno et al., 2000; Sandy et al., 2001). In this
study, we have shown that XADAMTS1 can inhibit FGF
Fig. 6. Inhibition of FGF signaling by XADAMTS1. (A, B) Effects of XADAMTS1 on FGF- or activin-induced gene expression in animal caps. Animal caps were
dissected from embryos which had been injected with XADAMTS1 (1 or 2 ng) or XFD (1 ng) mRNA at the two-cell stage and treated with FGF2 (100 ng/ml) or with
activin (190 pM). Expression levels of Xbra (A, B, lower panel) and goosecoid (B, upper panel) at the stage equivalent to mid-gastrula were detected by real time RT-
PCR. This experiment was performed twice with 1 ng of XADAMTS1mRNA, leading to the same conclusion. (C) XADAMTS1 decreased the phosphorylated ERK1/2
protein downstream from FGF. Animal caps were dissected from embryoswhich had been injected with mRNA for FGF4 (50 pg/embryo) or a constitutively active form
of Ras (Ha-Ras*; 100 pg/embryo) with or without XADAMTS1 mRNA (500 or 1000 pg/embryo). ΔFGFR4a mRNA (500 pg/embryo) was a positive control for
inhibition of FGF signaling. (D) Inhibition of Xbra expression by XADAMTS1 was rescued by Ha-Ras* in whole embryos. Embryos were injected with XADAMTS1
mRNA (1 ng/embryo) with or without Ha-Ras* mRNA (25 pg/embryo) into the DER at the four-cell stage, and fixed at the mid-gastrula stage. Globin was used as a
control. Expression of Xbra was stained in purple. nβ-gal as a lineage tracer was stained in red. Arrowheads indicate the dorsal lip.
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XADAMTS1 for FGF signaling is based on the following
observations: (1) overexpression of XADAMTS1 in the
ectoderm or in the dorsal marginal zone causes phenotypes
similar to those embryos injected with dominant-negative types
of FGFR (Figs. 4 and 5) (Amaya et al., 1991; Hongo et al.,
1999); (2) XADAMTS1 inhibits Xbra expression and the
phosphorylation of ERK induced by FGF in animal caps (Fig.
6); (3) knockdown of XADAMTS1 in the ectoderm by MOab
sensitizes the animal cap to respond to FGF2 treatment (Fig. 8).
The expectation that XADAMTS1 acts outside of the cells isbased on the following observations as well as previously
reported data: (1) Myc-tagged XADAMTS1 localizes along the
cell membrane as assayed by confocal microscopy (data not
shown), and the mouse ADAMTS1 protein is reportedly
detected on the ECM (Kuno and Matsushima, 1998); (2)
deletion of the signal peptide (ΔSP) abolishes activity for the
inhibition of gastrulation (Fig. 4), and a Myc-tagged ΔSP
construct localizes inside the cell (data not shown); (3)
XADAMTS1 binds to heparin in vitro (Fig. 7), suggesting
that XADAMTS1 can associate with heparan sulfate proteo-
glycans in the ECM.
Fig. 7. Binding of the C-terminal region of XADAMTS1 to heparin. A Myc-
tagged wild type (XADAMTS1-MT), deletion constructs (ΔC1-MT, SP-
TCSTT-MT, and SP-CS1-MT), and FGF2 (FGF2-MT) were injected into the
animal pole region of both blastomeres at the two-cell stage. Extracts from stage
11 embryos were incubated with heparin beads, and the beads were washed with
lysis buffer containing 0.1 M, 0.5 M, or 1 M NaCl. The Myc-tagged proteins
binding to heparin beads were analyzed byWestern blotting. The mature form of
XADAMTS1 indicated by arrow was used for quantification. The percentage of
amount of protein bound to heparin beads against the amount of input was
indicated below each lane.
Fig. 8. Sensitization of animal caps to FGF by knockdown of XADAMTS1. (A)
Depiction of the partial exon–intron structure of XADAMTS1 gene and targets of
MOab and sequence alignment of exon 1–intron 1 splice junctions of the
XADAMTS1-a and -b (exon sequences are boxed; intron sequences are in lower
case). Sequences against MOa and MOb are underlined. (B) RT-PCR detecting
transcripts in MOab (20 ng and 40 ng) or 5 mmMO (80 ng)-injected embryos.
RT-, RT-PCR without reverse transcriptase reaction. (C) Animal cap assays for
the effect of MOab injection on FGF responsiveness. Animal caps were
dissected from embryos which had been injected with MOab (25 or 50 ng) or
5 mmMO (50 ng) with or without XADAMTS1 (12.5 or 25 pg) mRNA at the
two-cell stage and treated with FGF2 (50 ng/ml) as indicated. Expression levels
of Xbra at the stage equivalent to the mid-gastrula were detected by quantitative
real-time RT-PCR.
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Sprouty, Sef, or Mkp3 have been identified. These genes are
induced by FGF, and their products inhibit intracellular FGF
signal transduction (Furthauer et al., 2002; Hacohen et al., 1998;
Kawakami et al., 2003; Nutt et al., 2001; Tsang et al., 2002). In
contrast to these negative feedback modulators, XADAMTS1 is
induced by activin but not by FGF2 (Fig. 3) and most likely to
act outside the cell as discussed above. This result implies that
XADAMTS1 mediates the cross-talk between activin/nodal and
FGF signaling. However, we cannot exclude the possibility that
other signaling may be involved in the expression of
XADAMTS1 because, for example, it is expressed in the
presumptive ectoderm (Fig. 2Ba) where nodal/activin signaling
is lowered as assayed by distribution of phospho-Smad2 at the
late blastula stage (Faure et al., 2000). Taken together, our
results suggest that XADAMTS1 is a new type of negative
modulator for FGF signaling, which can function in a non-cell-
autonomous manner.
XADAMTS1 activity resides in the C-terminal region and is
independent of its protease activity
We have shown that the C-terminal region of XADAMTS1
has its own activity that does not require the metalloprotease
activity. The C-terminal region contains the CR, SR, and three
TSRs (referred to as TCSTT) and has activity to inhibit FGF
signaling (Figs. 4 and 5), possibly through binding to heparin/
heparan sulfate (Fig. 7). We have further shown that either theCR/SR or the TSRs are required but not sufficient for the
inhibition of gastrulation, and that the CR is required for full
activity of the C-terminal region (Figs. 4D and 5B). Consistent
with our data, it was recently reported that the C-terminal region
of human ADAMTS1 (corresponding to the TCSTT construct)
directly binds to VEGF, a member of the platelet-derived
growth factor (PDGF) family, to inhibit angiogenesis (Luque et
al., 2003). In addition, the composition of the TSR CR, and SR
(the called papilin cassette) is unique to the ADAMTS family
and the ECM-bound protein, papilin (Apte, 2004; Kramerova et
al., 2000). Although papilin has been shown to inhibit an
ADAMTS metalloprotease in vitro (Kramerova et al., 2000),
questions still remain, such as what is the molecular basis of the
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VEGF (Luque et al., 2003) or heparin (Fig. 7), and does this
cassette have a common function, or distinct roles for each
ADAMTS or papilin gene.
Regarding the protease activity, we have observed that
XADAMTS1, but not the point mutant of the prospective
protease catalytic domain, E352A, cleaves a human IgG
constant region-tagged protein in embryos (A. S., S. Matsuda,
and M. T., unpublished data), similar to human ADAMTS1,
which cleaves the hinge region of the human IgG Fc region
(Wei et al., 2002). However, we did not detect any difference
between the wild-type and protease activity-deficient constructs
in the phenotypes of injected embryos. This result implies that
principal substrates for the XADAMTS1 protease do not have
major roles in morphogenesis at least at blastula to gastrula
stages, supporting further possibility that a major role of
XADAMTS1 at early stages involves the C-terminal region
rather than the protease domain.
We have shown that SP-TCSTT as well as wild-type
XADAMTS1 binds to heparin (Fig. 7). It has been shown that
heparin or heparan sulfate also binds to FGF and FGFR, and
that heparan sulfate is essential for FGF signaling at the
extracellular level (Lin, 2004), raising the possibility that the
CR/SR with TSRs of XADAMTS1 interacts with heparan
sulfate to block the complex formation between FGF and
FGFR. However, SP-CS1, which binds to heparin (Fig. 7), does
not show biological activity when expressed in the Xenopus
embryo (Figs. 4 and 5). This suggests that the interaction with
heparan sulfate is not sufficient to inhibit FGF signaling.
Furthermore, because XADAMTS1 and SP-TCSTT bind to
heparin with lower affinity than FGF2 at 0.5 M NaCl (Fig. 7), it
is unlikely that the wild type as well as SP-TCSTT competes
with FGFs for heparan sulfate in vivo. Therefore, it is rather
conceivable that XADAMTS1 may form an improper complex
with FGF, FGFR, and heparan sulfate for interrupting their
signal transduction. This speculation is supported by a recent
paper which shows that mouse ADAMTS1 binds to FGF2 in
vitro (Krampert et al., 2005).
Role of XADAMTS1 in early embryogenesis
Though previous studies in mice have shown that
ADAMTS1 is expressed in several organs, including the brain,
heart, lung, kidney, limb bud, and placenta, during development
(E10 to E18) (Thai and Iruela-Arispe, 2002), this study has
shown for the first time its early developmental expression
patterns in vertebrates. We found that the early expression of
XADAMTS1 from the blastula to neurula overlaps with that of
FGF8 as well as maternal FGF2 in the ectoderm at the late
blastula stage (Fig. 2Ba, b) and with that of FGF4 and FGF8 in
the posterior mesoderm and dorsal ectoderm during gastrula
stages (Fig. 2Bd–g) (Christen and Slack, 1997; Hayashi et al.,
2004; Isaacs et al., 1994). This expression pattern of
XADAMTS1 is consistent with the idea that XADAMTS1
attenuates the effects of FGFs in these regions. This idea is also
supported by loss-of-function experiments in which knockdown
of XADAMTS1 in the presumptive ectoderm sensitizes animalcaps to FGF2 treatment (Fig. 8). Therefore, it is possible to
speculate that (1) XADAMTS1 may modulate mesoderm
formation because FGF4 acts with Xbra to form a positive
feedback loop whichmaintains mesodermal tissue at the gastrula
stage (Isaacs et al., 1994; Schulte-Merker and Smith, 1995); (2)
XADAMTS1may be involved in neural crest formation because
FGF8 as well as Wnt functions as an inducer for the neural crest
as has been shown in the Xenopus embryo (Monsoro-Burq et al.,
2005); and (3) XADAMTS1 may modulate the posteriorizing
activity of FGFs because inhibition of FGF signaling
anteriorizes embryos (Hongo et al., 1999).
At later stages, expression of XADAMTS1 in the brain,
pronephros, and heart anlage corresponds to that in the mouse
embryo (Thai and Iruela-Arispe, 2002), suggesting evolution-
arily conserved roles for ADAMTS1 in organogenesis.
Although ADAMTS1-knockout mice reportedly have no severe
defects in early embryogenesis, it is possible that there is
functional redundancy among ADAMTS genes at early
embryogenesis. Taken together, our data suggest a new role
for ADAMTS1 during early embryogenesis as a non-cell-
autonomous negative regulator of FGF.
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